Firstline Management of ALI: Primary Endpoint Results from STRIDE 30-day Analysis, Economic Perspectives, Clinical Case Review with Computer-Aided Thrombectomy, and Results from INDIAN-UP
Sunday, 10 September | 16:45 – 17:05 CET | Room 20
STRIDE Study Outcomes and an Economic Comparison of Treating ALI with CDT vs. Mechanical Aspiration Thrombectomy
Dr. Rafiuddin (Raf) Patel John Radcliffe Hospital, United Kingdom
Interim Results of the INDIAN-UP Trial and Acute Limb Ischemia Case Discussion
Prof. Gianmarco de Donato Università di Siena, Italy
Innovations in the Treament of Pulmonary Embolism and Management of Deep Vein Thrombosis with Computer-Aided Thrombectomy: Clinical Study Advancements and Case Review
Monday, 11 September | 13:00 – 14:00 CET | Auditorium 15
MODERATOR: Prof. Christoph Binkert Kantonsspital Winterthur, Switzerland
Introduction to the Session The History of Aspiration
Pulmonary Embolism - Primary Percutaneous Treatment of PE with Lightning™ 12 Intelligent Aspiration: Clinical Update and Experience
Current Status of Pulmonary Embolism Management
Prof. Stavros Konstantinides Universitätsmedizin Mainz, Germany
Clinical Evidence: EXTRACT-PE, Interim STRIKE-PE Study Results and STORM-PE Utilizing Lightning 12 for Primary Percutaneous ?Treatment of Pulmonary Embolism
Dr. John Moriarty UCLA, Los Angeles, USA
DVT - Can Early Thrombus Removal Improve the Outcomes for DVT Patients?
Current Status of DVT Management Iliofemoral DVT Case Discussions
Dr. Kush Desai Northwestern University Feinberg School of Medicine. Chicago, United States
Current Status of DVT Management Upper Limb DVT Case Discussions
Prof. Gerry O'Sullivan University Hospital Galway, Ireland
Physician images used with permission. Consents on file at Penumbra, Inc.
Product availability varies by country. Prior to use, please refer to the Instructions for Use (IFU) for complete product indications, contraindications, warnings, precautions, potential adverse events, and detailed instructions for use. Please click here for the complete IFU Risk Statements. Please contact your local Penumbra representative for more information.
